XML 31 R76.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Stock Appreciation Rights) (Details) (USD $)
In Millions, except Share data, unless otherwise specified
1 Months Ended 12 Months Ended
Nov. 30, 2013
Jun. 30, 2013
May 31, 2013
Sep. 30, 2012
May 31, 2012
Mar. 31, 2012
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Weighted Average Exercise Price                  
Options vested, outstanding (in shares)             121,953    
Share-based Compensation, Shares Authorized Under Stock Appreciation Rights, Exercise Price Range, Number Of Unvested Shares             839,505    
Weighted Average Exercise Price Per Share (in dollars per share)             $ 22.20    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms             9 years 1 month 6 days    
Number of exercisable options (in shares)             121,953    
Weighted average exercise price per share (in dollars per share)             $ 21.65    
$19.65 - $22.70
                 
Weighted Average Exercise Price                  
Options vested, outstanding (in shares)             77,576    
Share-based Compensation, Shares Authorized Under Stock Appreciation Rights, Exercise Price Range, Number Of Unvested Shares             783,239    
Weighted Average Exercise Price Per Share (in dollars per share)             $ 21.98    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms             9 years 1 month 6 days    
Number of exercisable options (in shares)             77,576    
Weighted average exercise price per share (in dollars per share)             $ 20.47    
$23.03 - $26.22
                 
Weighted Average Exercise Price                  
Options vested, outstanding (in shares)             44,377    
Share-based Compensation, Shares Authorized Under Stock Appreciation Rights, Exercise Price Range, Number Of Unvested Shares             56,266    
Weighted Average Exercise Price Per Share (in dollars per share)             $ 24.07    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms             8 years 6 months    
Number of exercisable options (in shares)             44,377    
Weighted average exercise price per share (in dollars per share)             $ 23.73    
Stock Appreciation Rights (SARs)
                 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Granted (in shares)             923,832    
Fair value assumptions                  
Risk-free interest rate (as a percent) 1.91% 1.41% 1.17% 1.00% 1.18% 1.56%      
Dividend yield (as a percent) 3.13% 3.56% 3.61% 3.80% 4.20% 3.50%      
Expected life 6 years 6 months 6 years 6 months 6 years 6 months 6 years 6 months 6 years 6 months 6 years 6 months      
Volatility (as a percent) 43.80% 44.10% 44.10% 44.30% 44.00% 43.90%      
SAR grant price $ 26.22 $ 23.03 $ 22.70 $ 21.37 $ 19.65 $ 23.73      
Fair value of SAR award (in dollars per share) $ 8.60 $ 7.07 $ 6.86 $ 6.20 $ 4.77 $ 6.10 $ 22.76    
Number of Shares                  
Outstanding at beginning of period (in shares)             525,287 0  
Granted (in shares)             923,832 707,012  
Exercised (in shares)             (11,037)    
Forfeited/expired (in shares)               (181,725)  
Forfeited (in shares)             (476,624)    
Outstanding at end of period (in shares)             961,458 525,287  
Weighted Average Exercise Price                  
Outstanding at beginning of period             $ 21.23 $ 0.00  
Granted             $ 22.76 $ 21.23  
Exercised             $ 19.65    
Forfeited/expired             $ 22.28 $ 21.23  
Outstanding at end of period             $ 22.20 $ 21.23  
Outstanding - Aggregate Intrinsic Value             $ 5.6 $ 1.2 $ 0
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Exercised             0.1    
Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Exercisable, Weighted Average Remaining Contractual Terms             8 years 6 months    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested             0.8    
Unrecognized stock-based compensation expense             $ 4.8    
Unrecognized stock-based compensation expense, period of recognition             4 years 73 days    
Unvested stock appreciation rights                  
Nonvested at the beginning of the period (in shares)             525,287    
Granted (in shares)             923,832    
Vested stock appreciation rights (in shares)             (121,953)    
Exercised stock appreciation rights (in shares)             (11,037)    
Forfeited stock appreciation rights (in shares)             (476,624)    
Nonvested at the end of the period (in shares)             839,505 525,287  
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]                  
Nonvested at the beginning of the period (in dollars per share)             $ 21.23    
Granted (in dollars per share) $ 8.60 $ 7.07 $ 6.86 $ 6.20 $ 4.77 $ 6.10 $ 22.76    
Vested (in dollars per share)             $ 21.65    
Exercised (in dollars per share)             $ 19.65    
Forfeited (in dollars per share)             $ 22.28    
Nonvested at the end of the period (in dollars per share)             $ 22.27 $ 21.23  
Stock Appreciation Rights (SARs) | Minimum
                 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period (in years)             1 year    
Stock Appreciation Rights (SARs) | $19.65 - $22.70
                 
Weighted Average Exercise Price                  
Range of Exercisable Prices, low end of range (in dollars per share)             $ 19,650.00    
Range of Exercisable Prices, high end of range (in dollars per share)             $ 22,700.00    
Stock Appreciation Rights (SARs) | $23.03 - $26.22
                 
Weighted Average Exercise Price                  
Range of Exercisable Prices, low end of range (in dollars per share)             $ 23,030.00    
Range of Exercisable Prices, high end of range (in dollars per share)             $ 26,220.00    
1995 Executive Incentive Compensation Plan | Stock Appreciation Rights (SARs)
                 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Granted (in shares)       43,058 345,502 318,452      
Unvested stock appreciation rights                  
Granted (in shares)       43,058 345,502 318,452      
2013 Equity and Incentive Compensation Plan | Stock Appreciation Rights (SARs)
                 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Expiration period (in years)             10 years    
Granted (in shares) 15,000 5,018 903,814            
Unvested stock appreciation rights                  
Granted (in shares) 15,000 5,018 903,814            
2013 Equity and Incentive Compensation Plan | Stock Appreciation Rights (SARs) | Maximum
                 
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                  
Vesting period (in years)             5 years